Clinical research is the single most important way in which we improve our healthcare – by identifying new means to prevent, diagnose and treat disease. Emerging from the COVID-19 pandemic, significant work has been undertaken across Scotland to remobilise our portfolio of research across all phases, treatment types and conditions. This session will showcase the strength and diversity of the portfolio, the deep scientific expertise, and dedicated research infrastructure – all helping share a more resilient system for the future.
*Please note that captions are currently auto-generated*
Video Chapters
0:00 Introduction - NHS Research Scotland Diabetes Research Champion: Professor Rory McCrimmon, and Network Manager Dr Anna Barnett
2:42 The Cardiac CARE Trial: An RCT of cardiac troponin guided cardioprotection therapy to prevent anthracycline cardiotoxicity - Dr Morag MacLean, Senior Trial Manager, Edinburgh Clinical Trials Unit, University of Edinburgh
19:27 An update regarding the Meso-ORIGINS study: part of the PREDICT-Meso International Accelerator - Dr Mark Neilly, Clinical Research Fellow, University of Glasgow
35:04 Treatment in Morning vs Evening (TIME) study - Dr Filippo Pigazzani, Clinical Research Fellow, School of Medicine, University of Dundee
52:34 Genetic testing and targeted intervention to prevent development and progression of Paget’s disease of bone - Professor Stuart Ralston, Versus Arthritis Professor of Rheumatology, Centre for Genomic and Experimental Medicine, University of Edinburgh
